Corcept Therapeutics Incorporated · NASDAQ:CORT

Ingalls & Snyder LLC reported a 6.80% stake in Corcept Therapeutics Incorporated (Schedule 13G/A)

Event Dec 31, 2025 · Filed Apr 21, 2026

Ingalls & Snyder LLC reported a 6.80% stake in Corcept Therapeutics Incorporated, 7,263,466 shares, as a passive investor on Dec 31, 2025. Filed Apr 21, 2026 (Schedule 13G/A).

Stake
6.80%
Shares
7,263,466
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
INGALLS & SNYDER LLC6.80%7,263,466

Source

View original at SEC

Related